Name: UMIN ID:
Unique ID issued by UMIN | UMIN000006047 |
---|---|
Receipt number | R000004626 |
Scientific Title | Panitumumab monotherapy for gemcitabine, TS-1 and CDDP tolerant or failure unresectable or recurrent cholangiocarcinoma, evaluation of safety and efficiency |
Date of disclosure of the study information | 2011/09/01 |
Last modified on | 2014/02/07 09:39:51 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/07/26 19:33:41 | ||
2 | Update | 2011/09/26 22:57:26 | Organization Organization Category of Funding Organization |
|
3 | Update | 2011/10/21 11:35:21 | Anticipated trial start date Date analysis concluded |
|
4 | Update | 2012/06/15 11:30:19 | Public title Public title Acronym |
|
5 | Update | 2012/06/15 11:30:58 | Narrative objectives1 Narrative objectives1 |
|
6 | Update | 2012/06/15 11:34:23 | Key inclusion criteria Key inclusion criteria |
|
7 | Update | 2014/02/07 09:39:51 | Email Last name of contact person Last name of contact person Address Address TEL Email1 |